Your browser doesn't support javascript.
loading
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.
Johnson, Nichola; Maguire, Sarah; Morra, Anna; Kapoor, Pooja Middha; Tomczyk, Katarzyna; Jones, Michael E; Schoemaker, Minouk J; Gilham, Clare; Bolla, Manjeet K; Wang, Qin; Dennis, Joe; Ahearn, Thomas U; Andrulis, Irene L; Anton-Culver, Hoda; Antonenkova, Natalia N; Arndt, Volker; Aronson, Kristan J; Augustinsson, Annelie; Baynes, Caroline; Freeman, Laura E Beane; Beckmann, Matthias W; Benitez, Javier; Bermisheva, Marina; Blomqvist, Carl; Boeckx, Bram; Bogdanova, Natalia V; Bojesen, Stig E; Brauch, Hiltrud; Brenner, Hermann; Burwinkel, Barbara; Campa, Daniele; Canzian, Federico; Castelao, Jose E; Chanock, Stephen J; Chenevix-Trench, Georgia; Clarke, Christine L; Conroy, Don M; Couch, Fergus J; Cox, Angela; Cross, Simon S; Czene, Kamila; Dörk, Thilo; Eliassen, A Heather; Engel, Christoph; Evans, D Gareth; Fasching, Peter A; Figueroa, Jonine; Floris, Giuseppe; Flyger, Henrik; Gago-Dominguez, Manuela.
Affiliation
  • Johnson N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. nichola.johnson@icr.ac.uk.
  • Maguire S; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Ireland, UK.
  • Morra A; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Kapoor PM; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Tomczyk K; Faculty of Medicine, University of Heidelberg, Heidelberg, Germany.
  • Jones ME; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
  • Schoemaker MJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Gilham C; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Bolla MK; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
  • Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Ahearn TU; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Andrulis IL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
  • Anton-Culver H; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.
  • Antonenkova NN; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Arndt V; Department of Epidemiology, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, CA, USA.
  • Aronson KJ; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
  • Augustinsson A; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Baynes C; Department of Public Health Sciences, and Cancer Research Institute, Queen's University, Kingston, ON, Canada.
  • Freeman LEB; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
  • Beckmann MW; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Benitez J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
  • Bermisheva M; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Blomqvist C; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
  • Boeckx B; Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Bogdanova NV; Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.
  • Bojesen SE; Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Brauch H; Department of Oncology, Örebro University Hospital, Örebro, Sweden.
  • Brenner H; VIB Center for Cancer Biology, Leuven, Belgium.
  • Burwinkel B; Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium.
  • Campa D; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
  • Canzian F; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
  • Castelao JE; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Chanock SJ; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Chenevix-Trench G; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Clarke CL; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Conroy DM; iFIT-Cluster of Excellence, University of Tübingen, Tübingen, Germany.
  • Couch FJ; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Cox A; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Cross SS; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Czene K; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Dörk T; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Eliassen AH; Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, Heidelberg, Germany.
  • Engel C; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Evans DG; Department of Biology, University of Pisa, Pisa, Italy.
  • Fasching PA; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Figueroa J; Oncology and Genetics Unit, Instituto de Investigacion Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.
  • Floris G; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
  • Flyger H; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Gago-Dominguez M; Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
Br J Cancer ; 124(4): 842-854, 2021 02.
Article in En | MEDLINE | ID: mdl-33495599
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pregnanediol / Progesterone / Breast Neoplasms / Receptors, Progesterone / Receptors, Estrogen / Cytochrome P-450 CYP3A / Estrone Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Br J Cancer Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pregnanediol / Progesterone / Breast Neoplasms / Receptors, Progesterone / Receptors, Estrogen / Cytochrome P-450 CYP3A / Estrone Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Br J Cancer Year: 2021 Document type: Article Affiliation country: Country of publication: